Efficacy of an intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis

Bone Marrow Transplantation

Volumn 29, Issue 6, 2002, Pages 473-477

  Cairoli, R ^a   Grillo, G ^a   Tedeschi, A ^a   Gargantini, L ^a   Marenco, P ^a   Tresoldi, E ^a   Barbarano, L ^a   Nosari, A M ^a   Morra, E ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

ASCT; Mediastinal large B cell lymphoma with sclerosis

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VACOP B PROTOCOL; VACOP-B PROTOCOL; VINCRISTINE; ANTIBIOTIC AGENT; CARMUSTINE; CISPLATIN; CYTARABINE; DEXAMETHASONE; GALLIUM 67; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; NARCOTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; B CELL LYMPHOMA; DRUG ADMINISTRATION; DRUG EFFECT; EVALUATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LARGE CELL LYMPHOMA; MALE; MEDIASTINUM TUMOR; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RADIATION EXPOSURE; RISK FACTOR; SCLEROSIS; THORAX; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HIGH RISK PATIENT; IMMUNOSUPPRESSIVE TREATMENT; MEDIASTINUM CANCER; MUCOSA INFLAMMATION; MULTIPLE SCLEROSIS; PAIN; PATIENT SELECTION; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RISK ASSESSMENT; SEPSIS; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; STOMATITIS; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; PREDNISONE; PROGNOSIS; RISK FACTORS; SCLEROSIS; THORAX; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE;

EID: 0036010961     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703401     Document Type: Article

References (27)

1. A revised European-American classification of lymphoid neoplasms: A proposal from International Lymphoma Study Group
2. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. A poor prognostic subset of patients with non-Hodgkin's lymphoma
3. Primary mediastinal lymphoma in adults
4. Large-cell and immunoblastic lymphoma of the mediastinum: Prognostic features and treatment outcome in 57 patients
5. Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy
6. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: A multicentre study of 106 patients
7. Mediastinal large-B-cell-lymphoma with sclerosis: A clinical study of 21 patients
8. Mediastinal large-cell lymphoma with sclerosis
9. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin lymphoma
10. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma
11. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: Results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group
12. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: Mediastinal localization predicts for a favorable outcome
13. Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: A retrospective series on 126 patients from a single center
14. Primary diffuse large B-cell lymphoma of the mediastinum: Outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation
15. The non-Hodgkin's lymphoma classification project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
16. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and non-Hodgkin's lymphoma in first complete remission: A study of 466 patients
17. Benefit of autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2
18. Report of the committee on Hodgkin's disease staging classifications
19. Results of high dose therapy and autologous bone marrow/stem cell transplantation in poor-risk intermediate and high grade lymphoma
20. MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis
21. MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease
22. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethazone (DHAP)
23. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non Hodgkin Lymphoma
24. EBMT: Statistical guidelines
25. Primary mediastinal B cell lymphoma with sclerosis: An aggressive tumor with distinctive clinical and pathologic features
26. Primary mediastinal large B-cell lymphoma: The need for prospective controlled clinical trials
27. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high grade non-Hodgkin lymphoma